查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1663432

造影劑市場，按產品、按方式、按給藥途徑、按應用、按最終用途、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Contrast Media Market, By Product, By Modality, By Route of Administration, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年造影劑市場規模價值為 65.142 億美元，2025 年至 2032 年期間的複合年成長率為 8.00%。

造影劑市場-市場動態

醫療支出增加

市場擴張的主要驅動力是醫療保健支出的成長。預計近年來許多國家的醫療支出大幅上漲將對市場產生影響。例如，在預測期內，由於可支配收入的增加，醫療設施支出的預期成長將推動各種診斷影像對造影劑的需求。例如，醫療保健支出佔 2022 年美國 GDP 的 18.3%，高於 2019 年的 17.6%。因此，醫療費用的上漲將極大地影響先進醫療設施的採用。因此，造影劑市場的擴張預計將受到各國增加醫療保健支出的推動，以改善醫療保健基礎設施，滿足患者日益成長的需求，並提供尖端的醫療服務。

造影劑市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 8.00%

根據產品細分，預計碘化物將在 2024 年佔據最大市場佔有率

根據給藥途徑細分，靜脈注射是 2024 年的主要細分市場

根據應用細分，神經系統疾病是 2024 年的主要細分領域

根據最終用途細分，醫院將成為 2024 年的主要細分市場

從地區來看，北美是 2024 年最大的收入來源

造影劑市場-細分分析：

全球造影劑市場根據產品、方式、給藥途徑、應用、最終用途和地區進行細分。

根據產品，市場分為微泡、碘化、钆基和鋇基。 2024 年，碘化物將佔據市場主導地位，這歸因於 CT 和 X光技術的廣泛使用以及穩定的非離子碘化物質可用於更好的診斷。雖然鋇基造影劑有時用於口服和直腸給藥，但碘造影劑通常透過靜脈注射。使用以碘為基礎的造影劑可以改善 CT 和 X 光影像。此外，它們還用於改善大腦、軟組織、動脈和靜脈、內臟和胃腸道的成像。除了癌症之外，碘造影劑還可用於多種疾病，例如神經系統、胃腸道、腎臟病、心血管和肌肉骨骼問題。

根據應用，市場分為肌肉骨骼疾病、癌症、腎臟疾病、心血管疾病、胃腸道疾病、神經系統疾病和其他疾病。 2024 年，神經系統疾病類別佔據主導地位。由於 MRI 造影劑比 CT 能產生更優質的腦結構影像，因此鼓勵使用它們來對神經系統疾病的中樞神經系統進行診斷評估。钆基造影劑用於顯影脫髓鞘、發炎和腫瘤病變。在三分之一的 MRI 中，使用钆基造影劑來改善影像品質。透過使血管、發炎和腫瘤更加明顯，這些造影劑提高了診斷的準確性。美國用於診斷神經系統疾病的三種最常用的大環钆造影劑是Gadavist、Dotarem和Prohance。成人和兩歲及以上的兒童可以透過靜脈注射來觀察異常血管化的大腦、脊椎和相關組織異常。

造影劑市場-地理洞察

2024 年，北美在全球造影劑市場佔據主導地位。政府和非政府組織對生物醫學研究的資助增加是該市場崛起的主要原因。例如，2022 年 10 月 3 日，SNMMI 宣布撥款 10 萬美元用於治療小葉乳房腫瘤的核子醫學影像研究和開發。預計這將導致大幅擴張。該領域資金的增加使得許多研究計畫得以開展，這將為需要造影劑的新產品的發布帶來更多創意。此外，投資醫療設備的新創企業數量不斷增加是推動該地區市場收入成長的另一個驅動力。

然而，在整個預測期內，預計亞太地區的複合年成長率最快。這是因為醫療保健基礎設施越來越好，人們也越來越意識到早期診斷的重要性。此外，推動該地區市場收入成長的另一個原因是癌症、神經系統疾病、腸道疾病和心血管疾病（CVD）等慢性疾病的發生率不斷上升。例如，根據世界衛生組織 (WHO) 的數據，在印度，非傳染性疾病佔所有死亡人數的 63%，其中心血管疾病佔死亡人數的 27%。此外，預計新創企業數量的增加將顯著影響創新分子影像技術的數量。在整個預測期內，預計他們還有望加速市場擴張。

造影劑市場-競爭格局：

主要公司有拜耳公司、通用電氣公司、Jodas Expoim Pvt。 Ltd.、Lantheus 和 Guerbet 等公司正在採用合併、收購和合作等策略來擴大其市場佔有率。此外，他們也正在推出新產品。為了增加客戶群和國際市場佔有率，各大公司都在進行併購。收購為公司提供了更好的投資組合和更廣泛的地理覆蓋範圍，有助於它們擴大影響力。疾病指徵延伸在該行業很普遍，因為它使公司能夠獲得特定人口群體的信任。透過獲得某些適應症的批准，企業可以提高其產品的採用率並針對特定的患者群體。例如，2023 年 4 月，GE HealthCare 推出了用於磁振造影 (MRI) 的大環非離子钆基造影劑 (GBCA) Pixxoscan (gadobutrol)，擴大了其造影劑的範圍。 Pixxoscan 透過分散程序 (DCP) 進行監管評估後，在奧地利獲得了行銷許可。

近期發展

2024 年 8 月：拜耳公司表示，一種具有更好的弛豫性和安全性的新型钆基造影劑的 III 期臨床試驗已經完成。這種藥劑可為神經學應用提供改進的 MRI 成像能力。

2024 年 4 月：GE Healthcare 推出了一種新型 AI 造影劑注射裝置，旨在透過最佳化造影劑劑量和時間來定製成像方案，從而提高影像品質並降低造影劑腎病變的風險。

2024 年 3 月：美國食品藥物管理局批准了 Lantheus Holdings Inc. 的 DEFINITY（Perflutren 脂質微球）補充新藥申請 (sNDA)，DEFINITY 是一種超音波增強劑，旨在用於心臟超音波檢查不佳的兒科患者。

2023 年 6 月：美國食品藥物管理局批准了碘基造影劑 Iopromide-300 和 -370（Ultravist）。除了乳房 X 光照相和/或超音波之外，該產品還可用於觀察成人已知或疑似乳房病變。

目錄

第 1 章：造影劑市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 對比劑市場產品片段
    • 對比劑市場片段（按方式）
    • 造影劑市場依給藥途徑分類
    • 造影劑市場片段（按應用）
    • 造影劑市場片段（依最終用途）
    • 造影劑市場（按國家/地區）
    • 對比劑市場（按地區）
  • 競爭洞察

第 3 章：造影劑主要市場趨勢

  • 造影劑市場促進因素
    • 市場促進因素的影響分析
  • 顯影劑市場限制
    • 市場限制的影響分析
  • 造影劑市場機會
  • 造影劑市場未來趨勢

第 4 章：造影劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：造影劑市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠肺炎疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長領域
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：造影劑市場格局

  • 2024 年造影劑市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：造影劑市場 - 依產品分類

  • 概述
    • 按產品細分的佔有率分析
    • 微泡
    • 碘化
    • 钆基
    • 鋇基

第 8 章：造影劑市場 - 依方式

  • 概述
    • 依方式進行細分佔有率分析
    • 超音波
    • X光/電腦斷層掃描
    • 磁振造影

第 9 章：造影劑市場 - 依給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服途徑
    • 靜脈
    • 直腸給藥

第 10 章：造影劑市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 肌肉骨骼疾病
    • 癌症
    • 腎臟疾病
    • 心血管疾病
    • 胃腸道疾病
    • 神經系統疾病
    • 其他

第 11 章：造影劑市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 診斷影像中心
    • 其他

第 12 章：造影劑市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美造影劑主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品分類）
    • 北美市場規模及預測（依方式）
    • 北美市場規模及預測（按給藥途徑）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（依最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲造影劑主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（依產品分類）
    • 歐洲市場規模及預測（依方式）
    • 歐洲市場規模及預測（依管理途徑）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（依最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區造影劑主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太市場規模及預測（依產品分類）
    • 亞太市場規模及預測（依方式）
    • 亞太市場規模及預測（依管理途徑）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（依最終用途分類）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲造影劑主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品分類）
    • 拉丁美洲市場規模及預測（按方式）
    • 拉丁美洲市場規模及預測（按管理途徑）
    • 拉丁美洲市場規模與預測，按應用分類
    • 拉丁美洲市場規模及預測（依最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲造影劑主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品分類）
    • 中東和非洲市場規模及預測（按方式）
    • 中東和非洲市場規模及預測（按管理路線分類）
    • 中東和非洲市場規模及預測（按應用分類）
    • 中東和非洲市場規模及預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 13 章：主要供應商分析-造影劑產業

  • 競爭儀錶板
  • 公司簡介
    • Bayer AG
    • General Electric Company
    • Jodas Expoim Pvt. Ltd.
    • Lantheus
    • Guerbet
    • SANOCHEMIA Pharmazeutika GmbH
    • TAEJOON PHARM Co. Ltd.
    • Beijing Beilu Pharmaceuticals Company Limited
    • Bracco SpA
    • iMAX Diagnostic Imaging Limited
    • JB Chemicals & Pharmaceuticals Limited
    • Nano Therapeutics Pvt Ltd
    • Trivitron Healthcare
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4669

REPORT HIGHLIGHT

Contrast Media Market size was valued at US$ 6,514.2 Million in 2024, expanding at a CAGR of 8.00% from 2025 to 2032.

A contrast medium is a material that is used in medical imaging to improve the contrast of bodily fluid structures. Contrast media improve the visibility of the targeted blood vessels, tissues, or structures. In addition to emitting radiation, contrast media also change or absorb incoming electromagnetic or ultrasonic waves. MRIs and ultrasounds typically use one of the following contrast agents: barium-based, iodinated, gadolinium-based, or microbubble. Growing alliances and acquisitions among companies to launch new products, rising rates of cancer, neurological and cardiovascular illnesses, and new developments in contrast media are some of the reasons that are expected to propel the worldwide contrast media market throughout the forecast period. Moreover, some of the main factors propelling the growth of the contrast media market throughout the forecast period include rising incidence and prevalence of cancer and heart illnesses, growing demand for image-guided diagnostics and procedures, and technical improvements in medical imaging techniques. However, the high cost of the contrast media injectors and the negative consequences of using contrast media, such as bluish skin, vomiting, and stomach pains, are some of the factors holding back the growth of the worldwide contrast media market throughout the forecast period.

Contrast Media Market- Market Dynamics

Rise in healthcare spending

The primary driver of the market's expansion is the rise in healthcare spending. The market is anticipated to be impacted by the notable rise in medical expenditures in a number of nations in recent years. For instance, during the projection period, the demand for contrast media in various diagnostic imaging would be driven by the anticipated growth in healthcare facility spending due to the rise in disposable income. For example, healthcare expenditures made up 18.3% of the US GDP in 2022, up from 17.6% in 2019. Additionally, healthcare costs are rising in a number of countries, including Brazil and India. Thus, the adoption of sophisticated medical facilities will be greatly influenced by the rising costs of healthcare. Therefore, the expansion of the contrast media market is anticipated to be driven by countries' increased healthcare spending in order to improve the healthcare infrastructure, satisfy patients' increasing needs, and provide cutting-edge medical treatment.

Contrast Media Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2025-2032)

Based on product segmentation, the iodinated was predicted to show maximum market share in the year 2024

Based on route of administration segmentation, intravenous was the leading segment in 2024

Based on application segmentation, neurological disorders were the leading segment in 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Contrast Media Market- Segmentation Analysis:

The Global Contrast Media Market is segmented on the basis of Product, Modality, Route of Administration, Application, End-use, and Region.

On the basis of product, the market is segregated into Microbubble, Iodinated, Gadolinium-Based, and Barium-Based. In 2024, the market was dominated by the iodinated category, ascribed to the widespread use of CT and X-ray techniques as well as the accessibility of stable, nonionic iodinated substances for better diagnosis. Although barium-based contrast media are sometimes used for oral and rectal delivery, iodinated contrast media are typically given intravenously. CT and X-ray pictures are improved by using contrast media based on iodine. Additionally, they are employed to improve the imaging of the brain, soft tissues, arteries and veins, internal organs, and the gastrointestinal tract. In addition to cancer, iodinated contrasting media can be used for a wide range of indications, such as neurological, gastrointestinal, nephrological, cardiovascular, and musculoskeletal problems.

Based on application, the market is divided into Musculoskeletal Disorders, Cancer, Nephrological Disorders, Cardiovascular Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others. In 2024, the neurological disorders category held a dominant market share. Since MRI contrast media produce superior images of brain structures than CT, their use is encouraged by diagnostic evaluation of the central nervous system for neurological illnesses. Gadolinium-based contrast agents are used to visualize demyelinated, inflammatory, and neoplastic lesions. In one in three MRIs, gadolinium-based contrast agents are employed to improve picture quality. By making blood vessels, inflammation, and tumours more visible, these contrast agents increase the accuracy of the diagnosis. The three most often used macrocyclic gadolinium-based contrast agents in the United States for the diagnosis of neurological diseases are Gadavist, Dotarem, and Prohance. Adults and children two years of age and up may get them intravenously to view abnormally vascularized brain, spine, and related tissue abnormalities.

Contrast Media Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Contrast Media. The increased funding for biomedical research from both government and non-governmental groups is largely responsible for the market's rise. On October 3, 2022, for instance, SNMMI announced a US$100,000 award for nuclear medicine imaging research and development to address lobular mammary neoplasia. This is anticipated to lead to significant expansion. Increased financing in the area enables a lot of research projects, which will lead to more creative ideas for new product releases that require contrast media. Additionally, the growing number of start-ups investing in medical devices is another driver driving the rise of market revenue in this region.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. This is because healthcare infrastructures are getting better, and people are becoming more conscious of the importance of early diagnosis. Furthermore, another reason propelling the growth of this region's market revenue is the rising prevalence of chronic ailments like cancer, neurological disorders, intestinal illnesses, and cardiovascular diseases (CVDs). In India, for example, non-communicable diseases accounted for 63% of all deaths, with cardiovascular diseases accounting for 27% of these deaths, according to the World Health Organization (WHO). Moreover, The number of innovative molecular imaging techniques generated is anticipated to be significantly impacted by the growing number of startups. Throughout the projection period, they are also expected to accelerate market expansion.

Contrast Media Market- Competitive Landscape:

Major companies such as Bayer AG, General Electric Company, Jodas Expoim Pvt. Ltd., Lantheus, and Guerbet, among others, are using strategies including mergers, acquisitions, and partnerships to grow their market share. Additionally, they are launching new products. To increase their customer bases and market shares internationally, major firms are pursuing mergers and acquisitions. Acquisitions provide companies with a better portfolio and a wider geographic reach, which helps them expand their footprint. Disease indication extension is prevalent in this industry since it enables companies to gain the confidence of particular demographic groups. Through approvals for certain indications, businesses can boost the adoption of their products and target specific patient segments. For instance, in April 2023, by launching Pixxoscan (gadobutrol), a macrocyclic, non-ionic gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI), GE HealthCare broadened its range of contrast media. Pixxoscan obtained marketing clearance in Austria after undergoing regulatory evaluation through a decentralized procedure (DCP).

Recent Development

August 2024: Bayer AG said that a Phase III clinical trial for a new gadolinium-based contrast agent with a better relaxivity and safety profile had been completed. This agent may provide improved MRI imaging capabilities for neurological applications.

April 2024: A novel AI-powered contrast media injection device was introduced by GE Healthcare with the goal of enhancing image quality and lowering the risk of contrast-induced nephropathy by optimizing contrast dose and time for customized imaging regimens.

March 2024: The US Food and Drug Administration approved Lantheus Holdings Inc.'s supplemental new drug application (sNDA) for DEFINITY (Perflutren Lipid Microsphere), an ultrasound-enhancing agent intended for use in pediatric patients with poor echocardiograms.

June 2023: The US Food and Drug Administration authorized the iodine-based contrast agents Iopromide-300 and -370 (Ultravist). In addition to mammography and/or ultrasound, the product can be used to visualize known or suspected breast lesions in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTRAST MEDIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bayer AG
  • General Electric Company
  • Jodas Expoim Pvt. Ltd.
  • Lantheus
  • Guerbet
  • SANOCHEMIA Pharmazeutika GmbH
  • TAEJOON PHARM Co. Ltd.
  • Beijing Beilu Pharmaceuticals Company Limited
  • Bracco S.p.A.
  • iMAX Diagnostic Imaging Limited
  • J.B. Chemicals & Pharmaceuticals Limited
  • Nano Therapeutics Pvt Ltd
  • Trivitron Healthcare
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Microbubble
  • Iodinated
  • Gadolinium-Based
  • Barium-Based

GLOBAL CONTRAST MEDIA MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Ultrasound
  • X-ray/Computed Tomography
  • Magnetic Resonance Imaging

GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral Route
  • Intravenous
  • Rectal Route

GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Musculoskeletal Disorders
  • Cancer
  • Nephrological Disorders
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

GLOBAL CONTRAST MEDIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Contrast Media Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Contrast Media Market Snippet by Product
    • 2.1.2. Contrast Media Market Snippet by Modality
    • 2.1.3. Contrast Media Market Snippet by Route of Administration
    • 2.1.4. Contrast Media Market Snippet by Application
    • 2.1.5. Contrast Media Market Snippet by End-use
    • 2.1.6. Contrast Media Market Snippet by Country
    • 2.1.7. Contrast Media Market Snippet by Region
  • 2.2. Competitive Insights

3. Contrast Media Key Market Trends

  • 3.1. Contrast Media Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Contrast Media Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Contrast Media Market Opportunities
  • 3.4. Contrast Media Market Future Trends

4. Contrast Media Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Contrast Media Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Contrast Media Market Landscape

  • 6.1. Contrast Media Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Contrast Media Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Microbubble
    • 7.1.3. Iodinated
    • 7.1.4. Gadolinium-Based
    • 7.1.5. Barium-Based

8. Contrast Media Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Ultrasound
    • 8.1.3. X-ray/Computed Tomography
    • 8.1.4. Magnetic Resonance Imaging

9. Contrast Media Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 9.1.2. Oral Route
    • 9.1.3. Intravenous
    • 9.1.4. Rectal Route

10. Contrast Media Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Musculoskeletal Disorders
    • 10.1.3. Cancer
    • 10.1.4. Nephrological Disorders
    • 10.1.5. Cardiovascular Disorders
    • 10.1.6. Gastrointestinal Disorders
    • 10.1.7. Neurological Disorders
    • 10.1.8. Others

11. Contrast Media Market - By End-use

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Others

12. Contrast Media Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Contrast Media Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Contrast Media Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Contrast Media Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Contrast Media Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Contrast Media Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Contrast Media Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Bayer AG
    • 13.2.2. General Electric Company
    • 13.2.3. Jodas Expoim Pvt. Ltd.
    • 13.2.4. Lantheus
    • 13.2.5. Guerbet
    • 13.2.6. SANOCHEMIA Pharmazeutika GmbH
    • 13.2.7. TAEJOON PHARM Co. Ltd.
    • 13.2.8. Beijing Beilu Pharmaceuticals Company Limited
    • 13.2.9. Bracco S.p.A.
    • 13.2.10. iMAX Diagnostic Imaging Limited
    • 13.2.11. J.B. Chemicals & Pharmaceuticals Limited
    • 13.2.12. Nano Therapeutics Pvt Ltd
    • 13.2.13. Trivitron Healthcare
    • 13.2.14. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us